Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Colonic Neoplasms × osimertinib × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 34 Lung Neoplasms 9 Neoplasms 6 Neoplasm Metastasis 5 Carcinoma 5 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thoracic Neoplasms 1 Stage IB-IIIA Non-small Cell Lung Carcinoma 1 Skin Neoplasms 1 Respiratory Tract Neoplasms 1 Respiratory Tract Diseases 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Noonan Syndrome 1 Non Small Cell Lung Cancer Metastatic 1 Neoplasms, Squamous Cell 1 Neoplasms by Site 1 NSCLC 1 Multiple Myeloma 1 Lymphoma 1 Lung Diseases 1 Locally Advanced or Metastatic EGFR T790M+ NSCLC 1 Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer 1 Hematologic Neoplasms 1 Gastrointestinal Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Squamous Cell 1 Bronchial Neoplasms 1

Interventions

Leucovorin 38 Fluorouracil 36 Oxaliplatin 34 Bevacizumab 34 Irinotecan 32 Cetuximab 23 Capecitabine 18 Panitumumab 14 IFL protocol 7 Folfox protocol 6 Radiotherapy 5 Nivolumab 5 Magnetic Resonance Spectroscopy 5 Immunohistochemistry 5 Gene Expression Profiling 5 Celecoxib 5 regorafenib 4 pembrolizumab 4 dehydroftorafur 4 Ramucirumab 4 Fluorodeoxyglucose F18 4 Floxuridine 4 aflibercept 3 Surgical Procedures, Operative 3 Sorafenib 3 Radiosurgery 3 Ipilimumab 3 Gemcitabine 3 Fentanyl 3 Drug Therapy 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡